D-1446-2020 Class II Terminated
FDA drug recall D-1446-2020 was initiated by Pfizer Inc. on Jul 20, 2020 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; potential loose metal overseal crimp defects. The recall status is terminated (terminated Dec 8, 2022). Affected quantity: 19,144 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 12, 2020
- Initiation Date
- Jul 20, 2020
- Termination Date
- Dec 8, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19,144 vials
Product description
Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA NDC 0409-9094-12
Reason for recall
Lack of Assurance of Sterility; potential loose metal overseal crimp defects.
Distribution pattern
United States including Puerto Rico
Code information
Lots: Tray lot: 13405DK Vial lot: 13-405 DK Exp. 1JUL2021, Tray lot: 17096DK Vial lot: 17-096-DK Exp. 1NOV2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1446-2020
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.